Schedule (route) |
Endpoint |
Vehicle |
Dose |
Treated/Control (%) |
Observations |
Q01DX001 (ip) |
mean survival time |
saline with Tween-80 |
5.3 mg/kg/injection |
140.0 |
Antitumor endpoint evaluated on day 60; 10/10 animals surviving on day 5 |
Q01DX001 (ip) |
mean survival time |
saline with Tween-80 |
8.0 mg/kg/injection |
151.0 |
Antitumor endpoint evaluated on day 60; 10/10 animals surviving on day 5 |
Q01DX001 (ip) |
mean survival time |
saline with Tween-80 |
12.0 mg/kg/injection |
142.0 |
Antitumor endpoint evaluated on day 60; 10/10 animals surviving on day 5 |
Q04DX003 (ip) |
mean survival time |
saline |
1.5 mg/kg/injection |
104.0 |
Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
Q04DX003 (ip) |
mean survival time |
saline |
3.0 mg/kg/injection |
113.0 |
Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
Q04DX003 (ip) |
mean survival time |
saline |
6.0 mg/kg/injection |
160.0 |
Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |
Q04DX003 (ip) |
mean survival time |
saline |
12.0 mg/kg/injection |
176.0 |
Antitumor endpoint evaluated on day 30; 06/06 animals surviving on day 5 |